A third shot shows virus-fighting abilities comparable with the protection provided by two doses against the original strain of the virus.
All rights reserved by www.dividendstocksreport.net
Pfizer and BioNTech say booster provides high level of protection against omicron in initial lab study
Leave a Reply
Get the daily email about stock.
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!